215 Metastatic NSCLC adenocarcinoma with extremely rare EGFR exon 21 p. (Leu833_His835delinsValValLeu) mutation is clinically sensitive to Osimertinib

We present the case of an individual with metastatic non-small cell lung cancer (NSCLC) adenocarcinoma with an extremely rare epidermal growth factor receptor (EGFR) exon 21 p. (Leu833_His835delinsValValLeu) mutation who has had a sustained clinical response to osimertinib for almost 3 years.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Tags: Case Reports Source Type: research